Target intelligence / Profile preview

ATP-dependent DNA helicase Q5 (RECQL5)

Target
RECQL5
Molecular classification
Enzyme (helicase, specifically a member of the RecQ helicase family), DNA helicase (superfamily 2, SFII)
01

Overview

ATP-dependent DNA helicase Q5 (RECQL5) is an enzyme belonging to the RecQ family of helicases, which play major roles in the maintenance of genomic integrity. RECQL5 is involved in regulating DNA repair, homologous recombination, replication, transcription, and chromosomal segregation[1][2][3][6]. It is unique among RecQ helicases in its interactions with RNA polymerase II and its ability to inhibit both transcription initiation and elongation, thereby reducing transcriptional stress and protecting genome stability in actively transcribed regions[1][2][5]. RECQL5 can unwind various DNA structures, promotes strand exchange and annealing activities, and suppresses inappropriate homologous recombination, especially at stalled or damaged replication forks[3][4][6]. Its function as a tumor suppressor is increasingly appreciated, and defects in RECQL5 lead to chromosomal instability and increased susceptibility to cancer. The gene has several isoforms, with RECQ5β being the predominant form localized to the nucleus[6]. No specific pharmacological agents targeting RECQL5 are clinically available; however, RECQL5's roles in DNA metabolism make it a promising research target for cancer therapeutics and genome integrity modulation.

Other names
RECQL5RECQ5RecQ5FLJ90603DNA 3'-5' helicase RecQ5DNA helicase, RecQ-like type 5RecQ protein-like 5RecQ protein 5RecQ helicase-like 5
02

Mechanism of action

Not applicable; no drugs targeting RECQL5 currently established

03

Biological functions

Genome maintenanceDNA repairHomologous recombination regulationReplication fork stabilizationTranscription regulationTelomere maintenanceChromosomal segregationProtein-DNA interactions
04

Disease associations

Cancer (tumor suppressor function via genome integrity maintenance)Potentially other genomic instability syndromes, though not directly linked like other RecQ helicases
05

Safety considerations

No specific safety concerns identified; therapeutic targeting would need to consider effects on genomic stability and potential for secondary malignancies
06

Biomarkers

RECQL5 expression or mutation status may be explored as a biomarker for genomic instability or cancer susceptibility, but not used clinically

Beyond the preview

Go deeper on ATP-dependent DNA helicase Q5 (RECQL5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP-dependent DNA helicase Q5 (RECQL5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call